Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Management of acquired aplastic anemia in children

    ... because time from diagnosis to 'final' treatment is directly related to outcome regardless of the therapeutic option chosen. The gold ... SCT with a graft of BM cells for those children with matched sibling donors. Conversely for children without a sibling donor the ...

    Research Article last updated 02/04/2013 - 2:05pm.

  2. Diagnosis and management of aplastic anemia

    ... is important because time from diagnosis to treatment is related to outcome regardless of the therapeutic option chosen. HSCT remains the mainstay of therapy for those with matched sibling donors, and results have improved even further in recent years. ...

    Research Article last updated 01/09/2012 - 11:03am.

  3. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia-a single-center experience.

    ... peripheral blood grafts from human leukocyte antigen -matched related (six cases) and unrelated donors (eight cases). MSCs were intravenously ...

    Research Article last updated 07/09/2013 - 2:48pm.

  4. Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (CHAMP)

    ... count < 20 x10^9/L No suitable fully matched related (6/6 match for human leukocyte antigen ( HLA )-A and B at ...

    Clinical Trial last updated 05/22/2017 - 11:00am.

  5. Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    ... or ethnic background. Prior transfusions from selected donor (as this could have cause recipient alloimmunization against the donor) Women of childbearing potential who currently are pregnant (HCG+) or ...

    Clinical Trial last updated 06/06/2016 - 2:42pm.

  6. Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

    ... or MPD Patients aged < 50 yrs at high risk for regimen related toxicity using standard high dose regimens; factors considered high ... antigen ( HLA )-identical related or an HLA-matched unrelated donor (Fred Hutchinson Cancer Research Center [FHCRC] ...

    Clinical Trial last updated 04/28/2016 - 2:45pm.

  7. Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

    ... 5-AzaC and the effect on grade II-IV GvHD when given after matched unrelated donor transplant (MUD). ... informed consent prior to participation in the study and any related procedures being performed. The effects of azacitidine on the ...

    Clinical Trial last updated 05/02/2016 - 2:07pm.

  8. 5K Run & Walk Houston, Texas

    ... had a bone marrow transplant thanks to an anonymous matched donor, but it failed to work. A second transplant the following year ... (MDS), paroxysmal nocturnal hemoglobinuria (PNH) and related bone marrow failure diseases. The Foundation’s strength ...

    Friendraising Walk last updated 03/24/2017 - 3:44pm.

  9. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... should be no readily available consenting HLA - matched related donor who is either matched fully matched or mismatched at only one ...

    Clinical Trial last updated 06/06/2016 - 3:37pm.

  10. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... should be no readily available consenting HLA - matched related donor who is either matched fully matched or mismatched at only one ...

    Clinical Trial last updated 06/03/2016 - 2:54pm.